Tidemark’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Tidemark’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.1K	Hold	85	–	–	﹤0.01%	395
2025 Q4	$17.6K	Hold	85	–	–	0.01%	368
2025 Q3	$15.2K	Hold	85	–	–	﹤0.01%	404
2025 Q2	$13.7K	Sell	85 -20	-19%	-$3.19K	﹤0.01%	414
2025 Q1	$17.9K	Hold	105	–	–	0.01%	358
2024 Q4	$17.5K	Hold	105	–	–	0.01%	362
2024 Q3	$18.1K	Hold	105	–	–	0.01%	352
2024 Q2	$16.2K	Hold	105	–	–	0.01%	355
2024 Q1	$16.1K	Hold	105	–	–	0.01%	371
2023 Q4	$16.6K	Buy	+105	New	+$15.1K	0.01%	357

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Tidemark's FBT Position: Q1 2026 in Review

Tidemark held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 85 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Tidemark first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $18.1K in Q3 2024. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Tidemark held 85 shares of First Trust NYSE Arca Biotechnology Index Fund worth $17.1K as of Q1 2026.
Tidemark left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Tidemark's portfolio in Q1 2026, its #395 holding.
Tidemark first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
Tidemark's First Trust NYSE Arca Biotechnology Index Fund position peaked at $18.1K in Q3 2024.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.